Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  The Lancet

• Publication date

  1979-11-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(79)92440-1PMID 91781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man

  1979cited by this paper
• Prolongation of kidney survival during and after cyclosporin A therapy.

  1979cited by this paper
• CYCLOSPORIN A: AN IMMUNOSUPPRESSIVE AGENT PREFERENTIALLY ACTIVE AGAINST PROLIFERATING T CELLS

  1979cited by this paper
• Tumor incidence in human allograft recipients.

  1979cited by this paper
• Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants.

  1979cited by this paper
• Cancer and survival after cadaveric donor renal transplantation.

  1979cited by this paper
• A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man.

  1978cited by this paper
• Cyclosporin A in patients receiving renal allografts from cadaver donors.

  1978cited by this paper
• Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.

  1978cited by this paper
• Cyclosporin A for the treatment of graft-versus-host disease in man.

  1978cited by this paper
• Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation.

  1978cited by this paper
• Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A.

  1978cited by this paper
• Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

  1977cited by this paper

• Post-Transplant Hepatocellular Carcinoma: Balancing Immunosuppression and Immune Checkpoint Inhibitors.

  2026cites this paper
• Immunosuppression Management in Heart Transplantation

  2025cites this paper
• Insights into the history and tendency of cardiac transplantation for heart failure: A bibliometric-based visual analysis

  2025cites this paper
• Liver Transplantation Outcomes in Younger Versus Older Adult Recipients: The Edmonton Experience

  2025cites this paper
• Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics

  2025cites this paper
• Redefining the Immunobiology of Organ Transplantation for New Clinical Horizons

  2025cites this paper
• A graft-to-recipient weight ratio of less than 0.7% under portal venous hemodynamics monitoring is a risk factor for early graft loss after living donor liver transplantation

  2025cites this paper
• Molecular Mechanisms of Ischemia/Reperfusion Injury and Graft Dysfunction in Liver Transplantation: Insights from Multi-Omics Studies in Rodent Animal Models

  2025cites this paper
• Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions

  2025cites this paper
• Bioinformatics analysis of ferroptosis-related hub genes and immunoinfiltration in myocardial ischemia/reperfusion following heart transplantation

  2025cites this paper
• Allogeneic, Xenogeneic, and Exogenic Hearts for Transplantation

  2025cites this paper
• ESTADO ACTUAL DEL TRASPLANTE RENAL EN CHILE A 58 AÑOS DEL PRIMERO; “MI VISIÓN”

  2025cites this paper
• Immunosuppression Post-Liver Transplant: End of the Calcineurin Era?

  2025cites this paper
• Calcineurin-NFAT signaling controls neutrophils´ ability of chemoattraction upon fungal infection.

  2024cites this paper
• Seven decades of organ transplantation: Out of the 20th and into the 21st century

  2024cites this paper
• Role of calcineurin in regulating renal potassium (K+) excretion: Mechanisms of calcineurin inhibitor‐induced hyperkalemia

  2024cites this paper
• The evolution of cyclosporine treatments for treatment of ocular surface diseases

  2024cites this paper
• Benchmark Outcomes in Deceased Donor Kidney Transplantation: A Multicenter Analysis of 80 996 Transplants From 126 Centers

  2024cites this paper
• The First Reciprocal Activities of Chiral Peptide Pharmaceuticals: Thymogen and Thymodepressin, as Examples

  2024cites this paper
• Chinese contributions to liver transplantation.

  2024cites this paper
• Long-Term Survival of Canadian Liver Transplant Recipients Remains Stagnant— A Cohort Study on the Evolution of Cause-Specific Mortality

  2024cites this paper
• Trends of liver transplantation in Asia

  2024cites this paper
• The Effect of Pringle Maneuver Applied during Living Donor Hepatectomy on the Ischemia-Reperfusion Injury Observed in the Donors and Recipients

  2024cites this paper
• Iscalimab Combined With Transient Tesidolumab Prolongs Survival in Pig‐to‐Rhesus Monkey Renal Xenografts

  2024cites this paper
• Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance

  2024cites this paper
• Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling

  2024cites this paper
• Multiple Shades of Gray—Macrophages in Acute Allograft Rejection

  2023cites this paper
• The Evolution of Liver Transplant Program in Pakistan and the Challenges Ahead

  2023cites this paper
• Protein kinases: drug targets for immunological disorders

  2023cites this paper
• Current Use of Immunosuppression in Liver Transplantation.

  2023cites this paper
• Problem to solution; from mammalian skin grafts to renal allograft rejection: a tale of 66 years of evolution of our understanding.

  2023cites this paper
• Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

  2023cites this paper
• On a Long and Winding Road: Alloantibodies in Organ Transplantation.

  2023cites this paper
• Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation

  2023cites this paper
• The development and prospects of liver surgery

  2023cites this paper
• New Developments and Challenges in Liver Transplantation

  2023cites this paper
• Pancreas Transplantation Today: Quo Vadis?

  2023cites this paper
• Exploring the milestones in anaesthesia that made liver transplantation a realistic therapeutic option for fatal liver failure: A story of 4 decades in a single centre.

  2023cites this paper
• Conventional and Novel Approaches to Immunosuppression in Lung Transplantation.

  2023cites this paper
• Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury

  2022cites this paper
• Abdominal Organ Preservation Solutions in the Age of Machine Perfusion

  2022cites this paper
• Intraoperative Doppler Ultrasound for Detection of Early Postoperative Vascular Complications in Orthotopic Liver Transplants

  2022cites this paper
• Immunosuppression, Compliance, and Tolerance After Orthotopic Liver Transplantation: State of the Art.

  2022cites this paper
• Fludrocortisone Among Adult Renal Transplant Recipients With Persistent Hyperkalemia: Single-Center Experience.

  2022cites this paper
• Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.

  2022cites this paper
• PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy

  2022cites this paper
• Immunosuppression and liver transplantation

  2022cites this paper
• Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications

  2022cites this paper
• In memoriam of Thomas Earl Starzl, the pioneer of liver transplantation

  2022cites this paper
• The most influential articles on kidney transplantation

  2022cites this paper
• Current status and outcomes in heart transplantation: a narrative review.

  2022cites this paper
• CD44 as a pathological marker for the early detection of calcineurin inhibitor-induced nephrotoxicity post kidney transplantation.

  2022cites this paper
• Megelőzhető-e a ciklosporin A okozta fogíny-hyperplasia a dentalis plakk eltávolításával?

  2022cites this paper
• A brief history of liver transplantation and transplant anesthesia

  2022cites this paper
• Dr. Thomas Earl Starzl (1926–2017): Father of Transplantation

  2022cites this paper
• Evolving liver transplantation in Pakistan: Future challenges

  2022cites this paper
• Case Report: Let Us Not Forget the Treatment That Some Patients Have Received—The Brief 50-Year History of a Kidney Transplant Survivor

  2022cites this paper
• Current Approaches in the Allocation of Liver Transplantation

  2022cites this paper
• Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation

  2022cites this paper
• Nephrology in Brazil

  2021cites this paper
• Advances in Rejection Management: Prevention and Treatment.

  2021cites this paper
• Prediction of drug-induced kidney injury in drug discovery

  2021cites this paper
• Immunosuppression in Liver Transplantation

  2021cites this paper
• Immunosuppression in liver and intestinal transplantation.

  2021cites this paper
• Creation of the ILTS Consensus Statements on DCD and Liver Perfusion: Defining the Future of Liver Transplantation by Returning to the Past.

  2021cites this paper
• Future of Liver Transplantation in Children

  2021cites this paper
• Risk Factors and Prognosis of New-Onset Chronic Kidney Disease Following Orthotopic Liver Transplantation: A Retrospective Case-Control Study

  2021cites this paper
• Can uric acid blood levels in renal transplant recipients predict allograft outcome?

  2021cites this paper
• Towards tolerance in liver transplantation.

  2021cites this paper
• Organ Transplantation: A Historical Perspective

  2020cites this paper
• Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function

  2020cites this paper
• Lung and Heart-Lung Transplantation and Other Therapies for Lung Failure

  2020cites this paper
• Cardiac Replacement, Assistance, Repair or Regeneration for Heart Failure

  2020cites this paper
• Rare phenomena of tacrolimus-induced gingival hyperplasia

  2020cites this paper
• TEST THE THEORY THAT ORAL FLUDROCORTISONE (0.5MG EVERY DAY FOR 8 DAYS) IS THE DECENT OPTION IN RECOGNIZING SALT-TOUCHY CASES

  2020cites this paper
• Pancreatic islet transplantation: toward definitive treatment for diabetes mellitus.

  2020cites this paper
• THIRTY YEARS OF TACROLIMUS IN CLINICAL PRACTICE.

  2020cites this paper
• Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model

  2020cites this paper
• Liver Transplantation for Alcohol-Related Liver Disease (ARLD): An Update on Controversies and Considerations

  2020cites this paper
• Involvement of heme oxygenase-1 in suppression of T cell activation by quercetin

  2020cites this paper
• The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

  2020cites this paper
• Evaluation of PLGA microspheres with triple regimen on long‐term survival of vascularized composite allograft – an experimental study

  2020cites this paper
• Novel immunological approach to asses donor reactivity of transplant recipients using a humanized mouse model.

  2020cites this paper
• Current status of liver transplantation in Europe.

  2020cites this paper
• Pancreas transplantation, bioengineering, and regeneration

  2020cites this paper
• References

  2020cites this paper
• Pancreas transplantation in the setting of multivisceral transplantation

  2020cites this paper
• History of organ transplantation and the development of key immunosuppressants

  2020cites this paper
• Assessing immunosuppressive drug concentrations in clinical practice

  2020cites this paper
• Calcineurin Inhibitors

  2019cites this paper
• Liver preservation prior to transplantation: Past, present, and future

  2019cites this paper
• The physiological changes of circulatory death with respect to organ donation

  2019cites this paper
• Pharmacology of mitochondrial permeability transition pore inhibitors

  2019cites this paper
• Cyclosporine A inhibits MRTF‐SRF signaling through Na+/K+ ATPase inhibition and actin remodeling

  2019cites this paper
• Coupled feedback regulation of nuclear factor of activated T-cells (NFAT) modulates activation-induced cell death of T cells

  2019cites this paper
• Long Term Remission of Hyper IgE Syndrome after Treatment with Cyclosporine-A: Clinic and Immunological Correlations

  2019cites this paper
• Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation

  2019cites this paper
• Islet Cell Transplant

  2019cites this paper
• Marked change in blood tacrolimus concentration levels due to grapefruit in a renal transplant patient

  2019cites this paper
• Transplantation versus liver resection in patients with hepatocellular carcinoma.

  2019cites this paper